Counterweights without softening: Hims & Hers was referred to the DOJ in February 2026 for potential federal law violations
7 patients were diagnosed with nonarteritic anterior ischemic optic neuropathy (NAION) , a condition that can lead to permanent vision loss
Journal of Pharmacy Technology
The Noom Microdose GLP-1 Program is a medically guided weight loss program that uses a lower dose of GLP-1 medication, if prescribed
Unlike prescription GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro for type 2 diabetes, Zepbound for obesity)which is actually a dual GIP/GLP-1 receptor agonistthese probiotic formulations contain specific bacterial strains, most commonly Lactobacillus and Bifidobacterium species, that manufacturers claim may stimulate endogenous GLP-1 secretion from intestinal L-cells
Triglycerides dropping from a baseline of 200 mg/dL to 144 mg/dL moves a person from the borderline-high category into the optimal range, reducing cardiovascular risk significantly in the process